GirentuximabImagingPETPurpose: The main objective of this preliminary analysis of the IMaging PAtients for Cancer drug selecTion (IMPACT)-renal cell cancer (RCC) study is to evaluate the lesion detection of baseline contrast-enhanced CT, [89Zr]Zr-DFO-girentuximab-PET/CT and [18F]FDG-PET/CT ...
Purpose: The main objective of this preliminary analysis of the IMaging PAtients for Cancer drug selecTion (IMPACT)-renal cell cancer (RCC) study is to evaluate the lesion detection of baseline contrast-enhanced CT, [89Zr]Zr-DFO-girentuximab-PET/CT and [18F]FDG-PET/CT in detecting ccRCC le...
目的对癌症药物选择(IMPACT)-肾细胞癌(RCC)的影像学患者进行初步分析的主要目的是评估基线造影增强CT [89Zr] Zr-DFO-girentuximab-PET的病变检测/ CT和[18F] FDG-PET / CT根据国际转移数据库协会(IMDC)风险模型检测具有良好或中度预后的转移性透明细胞肾细胞癌(mccRCC)患者的ccRCC病变。方法纳入2015年2月至2018...